BACKGROUND: Electrographic flow (EGF) mapping enables the dynamic detection of functional or active atrial fibrillation (AF) sources outside the pulmonary veins (PVs), and the presence or absence of these sources offers a novel framework for classifying and treating persistent AF patients based on the underlying pathophysiology of their AF disease. OBJECTIVE: The primary objective of the FLOW-AF trial is to evaluate the reliability of the EGF algorithm technology (Ablamap software) to identify AF sources and guide ablation therapy in patients with persistent AF. METHODS: The FLOW-AF trial (NCT04473963) is a prospective, multicenter, randomized clinical study in which patients with persistent or long-standing persistent AF who have failed prior PV isolation (PVI) undergo EGF mapping after confirmation of intact PVI. In total, 85 patients will be enrolled and stratified based on the presence or absence of EGF-identified sources. Patients with an EGF-identified source above the predetermined activity threshold of ≥26.5% will be randomized in a 1:1 fashion to PVI only vs PVI + ablation of EGF-identified extra-PV sources of AF. RESULTS: The primary safety endpoint is freedom from serious adverse events related to the procedure through 7 days following the randomization procedure; and the primary effectiveness endpoint is the successful elimination of significant sources of excitation with the target parameter the activity of the leading source. CONCLUSIONS: The FLOW-AF trial is a randomized study designed to evaluate the ability of the EGF mapping algorithm to identify patients with active extra-PV AF sources.

Ablacon Inc Wheat Ridge Colorado

Department of Cardiology Erasmus MC Rotterdam the Netherlands

Department of Cardiology Homolka Hospital Prague Czech Republic

Department of Cardiology Praxisklinik Herz und Gefaesse Dresden Germany

Department of Cardiology University Medical Center Hamburg Eppendorf Hamburg Germany

Helmsley Electrophysiology Center Icahn School of Medicine at Mount Sinai New York New York

Zobrazit více v PubMed

Calkins H., Hindricks G., Cappato R., et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017;14:e275–e444. PubMed PMC

January C.T., Wann L.S., Alpert J.S., et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014;130:e199–e267. PubMed PMC

Charitos E.I., Purerfellner H., Glotzer T.V., Ziegler P.D. Clinical classifications of atrial fibrillation poorly reflect its temporal persistence: insights from 1,195 patients continuously monitored with implantable devices. J Am Coll Cardiol. 2014;63:2840–2848. PubMed

Zaman J.A.B., Baykaner T., Clopton P., et al. Recurrent post-ablation paroxysmal atrial fibrillation shares substrates with persistent atrial fibrillation : an 11-center study. J Am Coll Cardiol EP. 2017;3:393–402. PubMed PMC

Clarnette J.A., Brooks A.G., Mahajan R., et al. Outcomes of persistent and long-standing persistent atrial fibrillation ablation: a systematic review and meta-analysis. Europace. 2018;20:f366–f376. PubMed

Berger W.R., Meulendijks E.R., Limpens J., et al. Persistent atrial fibrillation: a systematic review and meta-analysis of invasive strategies. Int J Cardiol. 2019;278:137–143. PubMed

Saglietto A., Ballatore A., Gaita F., et al. Comparative efficacy and safety of different catheter ablation strategies for persistent atrial fibrillation: a network meta-analysis of randomized clinical trials. Eur Heart J Qual Care Clin Outcomes. 2022;8:619–629. PubMed

Lim H.S., Hocini M., Dubois R., et al. Complexity and distribution of drivers in relation to duration of persistent atrial fibrillation. J Am Coll Cardiol. 2017;69:1257–1269. PubMed

Haissaguerre M., Hocini M., Sanders P., et al. Localized sources maintaining atrial fibrillation organized by prior ablation. Circulation. 2006;113:616–625. PubMed

Sanders P., Berenfeld O., Hocini M., et al. Spectral analysis identifies sites of high-frequency activity maintaining atrial fibrillation in humans. Circulation. 2005;112:789–797. PubMed

Narayan S.M., Krummen D.E., Shivkumar K., Clopton P., Rappel W.J., Miller J.M. Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial. J Am Coll Cardiol. 2012;60:628–636. PubMed PMC

Honarbakhsh S., Schilling R.J., Dhillon G., et al. A novel mapping system for panoramic mapping of the left atrium: application to detect and characterize localized sources maintaining atrial fibrillation. J Am Coll Cardiol EP. 2018;4:124–134. PubMed PMC

Verma A., Sarkozy A., Skanes A., et al. Characterization and significance of localized sources identified by a novel automated algorithm during mapping of human persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2018;29:1480–1488. PubMed

Haissaguerre M., Hocini M., Denis A., et al. Driver domains in persistent atrial fibrillation. Circulation. 2014;130:530–538. PubMed

Bellmann B., Lin T., Ruppersberg P., et al. Identification of active atrial fibrillation sources and their discrimination from passive rotors using electrographical flow mapping. Clin Res Cardiol. 2018;107:1021–1032. PubMed

Haines D.E., Kong M.H., Ruppersberg P., et al. Electrographic flow mapping for atrial fibrillation: theoretical basis and preliminary observations. J Interv Card Electrophysiol. 2022 [E-pub ahead of print Aug 15] PubMed PMC

Haines D.E., Kong M.H., Ruppersberg P., et al. Anatomic distribution of active sources identified using electrographic flow mapping. Heart Rhythm. 2022;19:S201–S202.

Gagyi R.B., Ruppersberg P., Kong M.H., Hoogendijk M., Wijchers S., Szili-Torok T. First-in-human demonstration of 18-month spatiotemporal stability of active atrial fibrillation source detected by electrographic flow mapping in persistent atrial fibrillation. HeartRhythm Case Rep. 2021;7:599–604. PubMed PMC

Szili-Torok T., Kis Z., Bhagwandien R., et al. Functional electrographic flow patterns in patients with persistent atrial fibrillation predict outcome of catheter ablation. J Cardiovasc Electrophysiol. 2021;32:2148–2158. PubMed PMC

Haines D.E., Kong M.H., Ruppersberg P., et al. Analysis of behavior of AF sources with electrographic flow mapping. Heart Rhythm. 2021;18:1626–1627.

Electrographic flow mapping of persistent atrial fibrillation: intra- and inter-procedure reproducibility in the absence of 'ground truth'